CEO Justin Hanka provides Update
--- MindBio Therapeutics is a clinical-stage biotechnology company pioneering new treatments for mental health…
CEO Update: Justin Hanka
--- MindBio Therapeutics is a clinical-stage drug development company that is pioneering psychedelic microdosing and…
Dr Rachael Sumner presents Microdosing PMS PMDD trials
--- MindBio Therapeutics is a clinical-stage biopharma that is pioneering psychedelic microdosing treatments designed…
PHASE 2a MICRODOSING TRIAL YIELDS SIGNIFICANT POSITIVE TOP LINE RESULTS IN DEPRESSION.
We've got great news to report as we progress MB22001 through clinical trials. MB22001 is a proprietary titratable…
End of 2023 Update
I'm very pleased to be giving this update for MindBio Therapeutics. It certainly has been a big year for us in terms…
Its Cancer. Though, it's their Depression we are Treating.
In a world first, this is a Phase 2B government-approved take-home trial of a psychedelic medicine (MB22001), a…
Clinical Trial Update October
--- MindBio Therapeutics is a clinical-stage drug development company that is pioneering psychedelic microdosing. With…
Rethinking Youth Mental Health
--- We must not let another generation struggle in silence. It's time to turn our attention to mental health…